San Francisco, CA, United States of America

Neil H Squires

This inventor holds 22 USPTO granted patents and 11 published patent applications, plus 8 CIPO patents and 15 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Gilead Sciences, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil H Squires. Retrieved from https://idiyas.com/inventor/neil-h-squires

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 11)

% Patents Active = 100.0

CIPO Patents = 8 (Patent Applications = 3)

EPO Patents = 15 (Patent Applications = 18)

Average Co-Inventor Count = 13.0

ph-index = 9

Forward Citations = 153(Granted Patents)

Company Filing History:

22 out of 946

Gilead Sciences, Inc.

patents

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

PD-1 Inhibitors

MCL-1 Inhibitors

Pyrrolizine Compounds

Phosphonamide Nucleotide Analogues

COT Modulators

Prodrugs

Nucleoside Analogs

Antiviral Treatment

Pharmaceutical Use

Cot Modulators

Substituted Compounds

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590062 - PD-1/PD-L1 inhibitors (2026-03-31),

2. 12338233 - PD-1/Pd-L1 inhibitors (2025-06-24),

3. 12162844 - MCL-1 inhibitors (2024-12-10),

4. 12161625 - Substituted pyrrolizine compounds and uses thereof (2024-12-10),

5. 12110305 - Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical use (2024-10-08),

6. 11905299 - Cot modulators and methods of use thereof (2024-02-20),

7. 11718637 - Prodrugs of 4'-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the same (2023-08-08),

8. 11643400 - MCL-1 inhibitors (2023-05-09),

9. 11555029 - PD-1/PD-L1 inhibitors (2023-01-17),

10. 11066414 - Cot modulators and methods of use thereof (2021-07-20),

11. 10988451 - MCL-1 inhibitors (2021-04-27),

12. 10899735 - PD-1/PD-L1 inhibitors (2021-01-26),

13. 10874640 - Substituted pyrrolizine compounds and uses thereof (2020-12-29),

14. 10710986 - PD-1/PD-L1 inhibitors (2020-07-14),

15. 10703733 - MCL-1 inhibitors (2020-07-07),

Title: The Innovative Journey of Neil H Squires

Introduction: Neil H Squires, a visionary inventor based in San Francisco, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Neil H Squires holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, with his most recent patent focusing on a revolutionary method for sustainable water purification.

Career Highlights: With a career spanning over two decades, Neil H Squires has worked with leading research institutions and tech companies to develop cutting-edge solutions. His work has been instrumental in advancing various industries and improving the quality of life for many.

Collaborations: Throughout his career, Neil H Squires has collaborated with top scientists, engineers, and innovators from around the world. His ability to work in multidisciplinary teams has led to the successful development of innovative technologies that have had a lasting impact.

Conclusion: Neil H Squires continues to push the boundaries of innovation, with his passion for creating solutions that address some of the world's most pressing challenges. His dedication to excellence and forward-thinking approach make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.